'Gut health': a new objective in medicine?

'Gut health' is a term increasingly used in the medical literature and by the food industry. It covers multiple positive aspects of the gastrointestinal (GI) tract, such as the effective digestion and absorption of food, the absence of GI illness, normal and stable intestinal microbiota, effective immune status and a state of well-being. From a scientific point of view, however, it is still extremely unclear exactly what gut health is, how it can be defined and how it can be measured. The GI barrier adjacent to the GI microbiota appears to be the key to understanding the complex mechanisms that maintain gut health. Any impairment of the GI barrier can increase the risk of developing infectious, inflammatory and functional GI diseases, as well as extraintestinal diseases such as immune-mediated and metabolic disorders. Less clear, however, is whether GI discomfort in general can also be related to GI barrier functions. In any case, methods of assessing, improving and maintaining gut health-related GI functions are of major interest in preventive medicine

Bridging the Gap Between Biofuels and Biodiversity Through Monetizing Environmental Services of Miscanthus Cultivation

Carbon neutrality in the transport sector is a key challenge for the growing bioeconomy as the share of biofuels has stagnated over the past decade. This can be attributed to basic economics and a lack of a robust market for these technologies. Consequently, more sustainable biomass supply concepts are required that reduce negative impacts on the environment and at the same time promote environmental services for sustainable agricultural cropping systems including erosion prevention, soil fertility improvement, greenhouse gas mitigation, and carbon sequestration. One promising concept is the cultivation of perennial biomass crops such as Miscanthus (Miscanthus Andersson) as biofuel feedstock. In this study, the multiple environmental services provided by Miscanthus are first explored and subsequently monetized. Then the integration of Miscanthus cultivation for biomass production into European agricultural systems is assessed. One hectare of Miscanthus provides society with environmental services to a value of 1,200 to 4,183 € a−1. These services are even more pronounced when cultivation takes place on marginal agricultural land. The integration of Miscanthus into existing agricultural practices aids both conservation and further optimization of socio-economic welfare and landscape diversification. As these environmental services are more beneficial to the public than the Miscanthus farmers, subsidies are required to close the gap between biofuels and biodiversity that are calculated based on the provision of environmental services. Similar approaches to that developed in this study may be suitable for the implementation of other biomass cropping systems and therefore help foster the transition to a bioeconomy

Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses

Necrotizing enterocolitis (NEC) is a devastating disease of premature infants. Probiotics decrease the risk of NEC in clinical and experimental studies. Antimicrobial peptides protect the gut against noxious microbes and shape the commensal microbiota, but their role in NEC remains unclear. We report that like in human ontogeny, the rat pup has low expression of Paneth cell antimicrobials, which increases rapidly during normal development. To investigate the expression of antimicrobial peptides in experimental NEC and the impact of probiotics on their expression, premature rats were divided into three groups: dam fed (DF), hand fed with formula (FF), or hand fed with formula containing Bifidobacterium bifidum (FF+BIF). All groups were exposed to asphyxia and cold stress. The expression of lysozyme, secretory phospholipase A(2), pancreatic-associated proteins 1 and 3 mRNA was elevated in the FF (NEC) group, compared to the DF and FF+BIF groups where disease was attenuated. We conclude that induction of antimicrobial peptides occurs in experimental NEC similar to that reported in human disease and is attenuated when disease is averted by probiotic B. bifidum. The induction of antimicrobial peptides is likely an adaptive mucosal response that is often not sufficient to prevent disease in the premature gut